Analysis News

In-depth stock market analysis, technical indicators, and investment commentary. Expert insights on market trends, valuations, and trading strategies.

Motley Fool's Stock Advisor Hits 987% Average Return: What Investors Should Know
Analysis Daniel Marsh

Motley Fool's Stock Advisor Hits 987% Average Return: What Investors Should Know

Stock Advisor's average return reaches 987% vs. S&P 500's 215%. The figure averages all recommendations, not subscriber portfolios. Annual fee $199, intro $99.

NVDA NFLX
Fubo Stock Gains 2% as HD Upgrade Targets Subscriber Retention
Analysis Daniel Marsh

Fubo Stock Gains 2% as HD Upgrade Targets Subscriber Retention

FuboTV shares climbed 2% Friday as the company rolled out 1080p streams for ESPN and Fox Sports, a move aimed at improving retention without raising prices.

FUBO
Bayern's 5-1 Rout Highlights Sports-Media Demand, Not Equity Value
Analysis Daniel Marsh

Bayern's 5-1 Rout Highlights Sports-Media Demand, Not Equity Value

Bayern Munich's 5-1 win over Stuttgart in the Bundesliga opener generated massive U.S. search interest, but for investors, the signal is sports-media attention, not equity value.

Cyabra Stock Soars 48.6% on Gaming Deal, Adding $2.1M to Market Cap
Analysis Daniel Marsh

Cyabra Stock Soars 48.6% on Gaming Deal, Adding $2.1M to Market Cap

Cyabra (CYAB) shares surged 48.6% after a gaming client signed a six-figure annual managed-services deal, adding $2.1 million to market value. Q2 revenue rose 39% but losses persist.

Disney+ to Premiere Toy Story 5 on Sept 23 After $1.13B Box Office Run
Analysis Daniel Marsh

Disney+ to Premiere Toy Story 5 on Sept 23 After $1.13B Box Office Run

Toy Story 5 hits Disney+ on September 23 following a $1.129 billion global box office performance, as Disney leverages the franchise to drive streaming engagement and merchandise revenue.

DIS
Loblaw Revives Tariff Tags, Highlights Margin Sensitivity
Analysis Daniel Marsh

Loblaw Revives Tariff Tags, Highlights Margin Sensitivity

Loblaw brings back 'T' tariff labels on shelves as trade friction widens, with CEO Per Bank noting stronger supply chain diversification.

L
FDA Approves Rasonque, Revolution Medicines Stock Holds Steady
Analysis Daniel Marsh

FDA Approves Rasonque, Revolution Medicines Stock Holds Steady

Revolution Medicines (RVMD) received FDA approval for Rasonque in pancreatic cancer, but shares rose only 0.8% as investors awaited launch details.

RVMD
McDonald's McGold Card Campaign Launches in Australia with Daily App Deals
Analysis Daniel Marsh

McDonald's McGold Card Campaign Launches in Australia with Daily App Deals

McDonald's launches its Australian McGold Card campaign with 30 daily app deals and nine lifetime prizes worth A$561,600. MCD shares slipped 0.39%.

MCD
CD Projekt Shares Dip as Free Witcher 3 Remaster Aims to Expand Player Base
Analysis Daniel Marsh

CD Projekt Shares Dip as Free Witcher 3 Remaster Aims to Expand Player Base

CD Projekt shares fell 0.8% despite the free Witcher 3 remaster announcement, as analysts weigh its potential to expand the player base ahead of a paid expansion.

GTA 6 Netflix Debut Could Decide Take-Two's $8.2B Revenue Goal
Analysis Daniel Marsh

GTA 6 Netflix Debut Could Decide Take-Two's $8.2B Revenue Goal

Take-Two's GTA 6 Netflix preview on Aug 27 is a key test for its $8.2B bookings target. Q1 bookings were $1.39B, leaving $6.6B+ to achieve.

TTWO NFLX
CRISPR Therapeutics Surges as Key Data Release Looms
Analysis Daniel Marsh

CRISPR Therapeutics Surges as Key Data Release Looms

CRISPR Therapeutics (CRSP) climbed 6.7% on Tuesday as investors await Friday's CTX310 clinical update. Citizens reaffirmed an $80 target, implying 31% upside.

CRSP VRTX
Nike Expands NFL Rivalries Lineup by Eight Teams After Record Fanatics Debut
Analysis Daniel Marsh

Nike Expands NFL Rivalries Lineup by Eight Teams After Record Fanatics Debut

Nike expands NFL Rivalries to 16 teams following a record Fanatics debut. New jerseys for eight teams arrive Sept 1, but financial impact remains unclear.

NKE